How And Why We Decided To Bring "Pathways" To Market

At Medable, our focus remains on comprehending the dynamic landscape of clinical research and devising solutions to assist clients in navigating the evolving challenges, risks, and scenarios that arise. Over the past year, this author has collaborated closely with a diverse team of clinicians and research experts to enhance Medable's research methodologies across various therapeutic domains.

Aligned with the findings outlined in Tufts CSDD's recent whitepaper, the team is a firm believer in the efficacy of a decentralized approach to expedite the introduction of novel therapies into historically challenging markets. The culmination of Medable's efforts is the development of a groundbreaking decentralized approach, which they are excited to introduce to the market under the banner of “pathways.”